PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 156 filers reported holding PRECIGEN INC in Q2 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,251 | +12.3% | 79,754 | -9.1% | 0.07% | +15.0% |
| Q2 2023 | $100,846 | +60.8% | 87,692 | +48.2% | 0.06% | +71.4% |
| Q1 2023 | $62,720 | -49.6% | 59,170 | -27.8% | 0.04% | -46.2% |
| Q4 2022 | $124,506 | -31.6% | 81,912 | -4.3% | 0.06% | -11.0% |
| Q3 2022 | $182,000 | +59.6% | 85,618 | +0.7% | 0.07% | +73.8% |
| Q2 2022 | $114,000 | +22.6% | 85,000 | +93.5% | 0.04% | 0.0% |
| Q1 2022 | $93,000 | -46.2% | 43,928 | -5.6% | 0.04% | -35.4% |
| Q4 2021 | $173,000 | +15.3% | 46,531 | +54.3% | 0.06% | -1.5% |
| Q3 2021 | $150,000 | -27.5% | 30,149 | -5.0% | 0.07% | -22.4% |
| Q2 2021 | $207,000 | -7.6% | 31,729 | -2.5% | 0.08% | -10.5% |
| Q1 2021 | $224,000 | -31.3% | 32,527 | +1.8% | 0.10% | -29.6% |
| Q4 2020 | $326,000 | – | 31,962 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |